CRA is a proud sponsor of the conference dedicated to providing invaluable opportunities for networking and collaboration with the chance to meet, engage with and learn from over 300 attorneys and executives from the biotech, pharmaceutical, and medical device industries and keep you up-to-date on the latest developments and challenges in the industry.
Kirsten Axelsen is a speaker during the session titled “MFN Drug Pricing and the Future of Global Pharmaceutical Markets: Understanding the Implications for Pricing, Access, and Innovation.”
For more information on this event, click here.
